Ładuje się......
TSHR as a therapeutic target in Graves’ disease
Graves’ disease (GD) and its extrathyroidal manifestations such as thyroid-associated ophthalmopathy (TAO) are thought to result from abnormal activities of pathogenic antibodies mediated through the thyrotropin receptor (TSHR). At the core of GD is the loss of immune tolerance to TSHR and the gener...
Zapisane w:
| Wydane w: | Expert Opin Ther Targets |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5718165/ https://ncbi.nlm.nih.gov/pubmed/28127991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2017.1288215 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|